Telix Pharmaceuticals Ltd
TLX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0002007191
No open-market purchases or sales by Telix Pharmaceuticals Ltd insiders were filed in the last 90 days; 62 institutions reported holding it in 13F filings for Q2 2026, worth $36.6M in total; no superinvestor holds it.
Other share classesTLPPF
Q2 2025 vs. Q1 2025
How the institutions holding Telix Pharmaceuticals Ltd changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 6 | 21 | +15 |
| Shares | 47.6K | 452.5K | +404.8K (+849.6%) |
| Value | $798.6K | $7.29M | +$6.49M (+812.3%) |
New holders (16)
Institutions that held Telix Pharmaceuticals Ltd at the end of Q2 2025 but not at the end of Q1 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Pier Capital, LLC | 188,992 | $3.04M | 0.46% |
| Russell Investments Group, Ltd. | 60,301 | $975.1K | 0.00% |
| FMR LLC | 42,091 | $680.6K | 0.00% |
| Citadel Advisors LLC | 41,328 | $668.3K | 0.00% |
| Jane Street Group, LLC | 35,103 | $564.1K | 0.00% |
| JustInvest LLC | 18,475 | $296.9K | 0.00% |
| Blair William & Co | 13,500 | $216.9K | 0.00% |
| IHT Wealth Management, LLC | 13,240 | $212.8K | 0.01% |
| Raymond James Financial Inc | 1,200 | $19.3K | 0.00% |
| SRS Capital Advisors, Inc. | 1,030 | $16.6K | 0.00% |
| Royal Bank of Canada | 141 | $2.00K | 0.00% |
| Advisor Group Holdings, Inc. | 45 | $723 | 0.00% |
| JFS Wealth Advisors, LLC | 27 | $434 | 0.00% |
| Principal Securities, Inc. | 21 | $337 | 0.00% |
| Assetmark, Inc | 18 | $289 | 0.00% |
| True Wealth Design, LLC | 10 | $161 | 0.00% |
Sold out (1)
Institutions that held Telix Pharmaceuticals Ltd at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Abc Arbitrage SA | 26,939 | $451.5K |